| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Adelene Q. Perkins | Director | $83,421 | 08 Sep 2023 | ||
| Anthony B. Evnin | Director | $15,078 | 16 Jun 2022 | ||
| Stephane Peluso | Chief Scientific Officer | $2,594 | 02 Aug 2022 | ||
| Brian Schwartz | Director | $2,164 | 16 Jun 2022 | ||
| Richard Gaynor | Director | 16 Jun 2022 | |||
| Norman C. Selby | Director | 16 Jun 2022 | |||
| Robert Ilaria Jr. | Chief Medical Officer | 11 Jan 2022 | |||
| Seth A. Tasker | Chief Business Officer | 11 Jan 2022 | |||
| David W. Beier | Director | 16 Jun 2022 | |||
| Lawrence E. Bloch | President | 11 Jan 2022 | |||
| Sujay Kango | Director | 30 Mar 2022 | |||
| Samuel Agresta | Director | 16 Jun 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||